Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Joshua Fritzler, president of the compounding pharmacy Olympia Pharmaceuticals, says the company has been preparing in advance of the anticipated changes, spending a lot of money to create these formulas to be ready if the FDA gives the green light
BPC-157, TB-500 20mg (Blend) $200,00 PRODUCT SHORT DESCRIPTION The BPC-157 and TB-500 formulation delivers an advanced, dual-action 20mg (20,000mcg) research blend combining two synergistic synthetic peptides in a single 10mg/10mg configuration
Preclinical models and emerging clinical experience suggest accelerated post-surgical healing, though controlled human trial data remain limited
The peptide does not affect liver metabolism in ways that would interact with alcohol processing
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice
US$ 24.14
US$ 20.67
US$ 22.45
US$ 25.74
US$ 20.80
US$ 22.37